Literature DB >> 28547755

Demographic and socioeconomic influences on Helicobacter pylori gastritis and its pre-neoplastic lesions amongst US residents.

R M Genta1,2, K O Turner1,2, A Sonnenberg3,4.   

Abstract

BACKGROUND: Gastric infection with Helicobacter pylori (Hp) can lead to chronic inactive gastritis, atrophy and intestinal metaplasia. AIMS: To investigate in a cross-sectional study these changes among different socioeconomic and ethnic groups within the USA.
METHODS: We used the Miraca Life Sciences database, an electronic depository of clinicopathological records from patients distributed throughout the USA, to extract data from 487 587 patients who underwent oesophago-gastro-duodenoscopy with biopsy between 1/2008 and 12/2014. We then classified patients into ethnic and socioeconomic categories using previously validated algorithms, as well as ZIP code-based information derived from the 2011-2012 US Census.
RESULTS: The prevalence of Hp increased significantly until the age-group 40-49, before it leveled off and started a gradual decrease. The prevalence of chronic inactive gastritis, atrophy, and intestinal metaplasia increased significantly with age. The prevalence of Hp, chronic inactive gastritis, intestinal metaplasia, and atrophy decreased significantly with the percentage of Whites per ZIP code. The prevalence of all four diagnoses also decreased significantly with rising levels of income or college education. Hp, chronic inactive gastritis, atrophy and intestinal metaplasia were more common among Hispanics and the influence of income or college education less pronounced than in the entire population. Hp, chronic inactive gastritis, atrophy, and intestinal metaplasia were also more common among East-Asians, Hp and atrophy decreasing with rising income but remaining unaffected by levels of college education.
CONCLUSION: Ethnicity and socioeconomic factors influence the occurrence of Hp gastritis, and its progression to chronic inactive gastritis, atrophy or intestinal metaplasia.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28547755     DOI: 10.1111/apt.14162

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Epidemiology of Helicobacter pylori in Australia: a scoping review.

Authors:  Jillian Congedi; Craig Williams; Katherine L Baldock
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

2.  Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population.

Authors:  Mimi C Tan; Taher Jamali; Theresa H Nguyen; Amy Galvan; Robert J Sealock; Anam Khan; Neda Zarrin-Khameh; Ashley Holloman; Ourania Kampagianni; David Henriquez Ticas; Yan Liu; Hashem B El-Serag; Aaron P Thrift
Journal:  Am J Gastroenterol       Date:  2022-02-01       Impact factor: 12.045

3.  Helicobacter pylori infection among patients presenting with dyspepsia at a primary care setting in Cameroon: seroprevalence, five-year trend and predictors.

Authors:  Jeannine A Aminde; Guisilla A Dedino; Calypse A Ngwasiri; Kingsley S Ombaku; Cedric A Mahop Makon; Leopold Ndemnge Aminde
Journal:  BMC Infect Dis       Date:  2019-01-08       Impact factor: 3.667

4.  Helicobacter pylori Prevalence in Laparoscopic Sleeve Gastrectomy Specimen.

Authors:  Nada A Sabbah; Carla Z Saoud; Mary Deeb; Selim M Nasser
Journal:  Gastroenterol Res Pract       Date:  2020-12-10       Impact factor: 2.260

5.  Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population.

Authors:  Theresa H Nguyen; Mimi C Tan; Yan Liu; Massimo Rugge; Aaron P Thrift; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2020-03-14       Impact factor: 11.382

6.  Gastric Intestinal Metaplasia: Demographic and Epidemiological Characterization in Puerto Rican Hispanics (2012-2014).

Authors:  Jorge J Cruz-Cruz; María González-Pons; Adrián Cora-Morges; Marievelisse Soto-Salgado; Giancarlo Colón; Kimberly Alicea; Kathia Rosado; Douglas R Morgan; Marcia Cruz-Correa
Journal:  Gastroenterol Res Pract       Date:  2021-02-23       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.